Cancer biomarkers : section A of Disease markers · 2020
miR-199a-5p suppresses epithelial- mesenchymal-transition in anaplastic thyroid carcinoma cells via targeting Snail signals.
Источник пометил эту публикацию как отозванную.
СтатьяНаблюдательное исследованиеОтозванная публикацияНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hao Fengyun, Bi Ya-Nan, Wang Lei, Wang Yubing, Ma Jilei, Cui Ping, Li Xuhua, Sun Shukai, Ning Liang, Huang Yichuan, Jiao Xuelong, Chen Dong
Аннотация
MicroRNAs (miRNAs) have been validated to play prominent roles in the occurrence and development of anaplastic thyroid carcinoma (ATC). miR-199a-5p was previously reported to act as a tumor suppressor or oncomiRNA in various types of cancer. However, its accurate expression, function, and mechanism in ATC remain unclear. Here, we find that miR-199a-5p is significantly downregulated in ATC tissues compared with adjacent non-cancerous tissues. Overexpression of miR-199a-5p significantly inhibits migration and invasion of ATC cells in vitro, and lung metastasis in vivo. Importantly, miR-199a-5p suppresses epithelial-mesenchymal transition (EMT) both in vitro and in vivo by targeting Snail. Taken together, this study reveals that miR-199a-5p is critical to the EMT progression in ATC cells. Targeting the pathway described here may be a novel approach for inhibiting metastasis of ATC.
Предметные рубрики MeSH
AnimalsBiopsy, Fine-NeedleCell Line, TumorCell MovementCell ProliferationDisease ProgressionDown-RegulationEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHumansLung NeoplasmsMiceMicroRNAsNeoplasm InvasivenessSnail Family Transcription FactorsThyroid Carcinoma, AnaplasticThyroid GlandThyroid NeoplasmsThyroidectomyXenograft Model Antitumor Assays